Atypical antipsychotic drugs were introduced in the early 1990s. Unlike typical
antipsychotics, which are effective only against positive symptoms of schizophrenia, atypical …

The second generation antipsychotic drug clozapine represents the most effective
pharmacotherapy for treatment-resistant psychosis. It is also associated with low rates of …

Background Anxiety disorders are the most prevalent mental illnesses in the US and are
estimated to consume one-third of the country's mental health treatment cost. Although …

Dopamine is a biologically active amine synthesized in the central and peripheral nervous
system. This biogenic monoamine acts by activating five types of dopamine receptors (D1 …

Atypical antipsychotics (AAs) may play a role in the treatment of anxiety disorders, obsessive-
compulsive disorder (OCD), and trauma-related disorders. No reviews on their differential …

Introduction: Agomelatine is a melatonergic antidepressant, approved for the treatment of
Major Depressive Disorder (MDD) in Europe and Australia, but not in the United States. This …

Schizophrenia is a chronic debilitating neuropsychiatric disorder estimated to affect 51
million people worldwide. Several symptom domains characterize schizophrenia, including …

Introduction: The prevalence of panic disorder (PD) in the population is high and these
patients have work impairment, high unemployment rates, seek medical treatment more …

Antipsychotic drugs represent the most effective treatment for chronic psychotic disorders.
The newer second generation drugs offer the advantage of fewer neurological side-effects …

To date, only a few studies compared some long-acting injectables (LAIs) antipsychotics
showing similar symptom improvement, relapse rates and adherence to treatment. We …